Estrogen receptor status confers a distinct pattern of response to neoadjuvant chemotherapy: implications for optimal durations of therapy: distinct patterns of response according to ER expression.
about
Phosphorylation of p90RSK is associated with increased response to neoadjuvant chemotherapy in ER-positive breast cancer.Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses.Neoadjuvant chemotherapy for different molecular breast cancer subtypes: a retrospective study in Russian population.Measurement of molecular biomarkers that predict the tumor response in estrogen receptor-positive breast cancers after dose-dense (biweekly) paclitaxel/carboplatin neoadjuvant chemotherapy.Clinicopathological predictors of long-term benefit in breast cancer treated with neoadjuvant chemotherapy.
P2860
Estrogen receptor status confers a distinct pattern of response to neoadjuvant chemotherapy: implications for optimal durations of therapy: distinct patterns of response according to ER expression.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Estrogen receptor status confe ...... se according to ER expression.
@en
type
label
Estrogen receptor status confe ...... se according to ER expression.
@en
prefLabel
Estrogen receptor status confe ...... se according to ER expression.
@en
P2093
P2860
P50
P1476
Estrogen receptor status confe ...... se according to ER expression.
@en
P2093
Bhumsuk Keam
Do-Youn Oh
In Ae Park
Nariya Cho
Sae-Won Han
Seock-Ah Im
Wonshik Han
Woo Kyung Moon
P2860
P2888
P304
P356
10.1007/S10549-012-2145-Y
P407
P577
2012-07-03T00:00:00Z
P6179
1051614571